Stay updated with breaking news from Testosterone Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A meta-analysis may provide some reassurance of the short-term cardiovascular safety of testosterone therapy for male hypogonadism until definitive 5-year TRAVERSE trial findings are available, expected in late 2022.
GP menopause specialists Dr Louise Newson and Dr Olivia Jones provides an overview of the evidence relating to HRT use and practical tips to help GPs prescribe appropriately.
NEW ORLEANS, May 13, 2022 /PRNewswire/ -- Patients are turning to social media channels more and more frequently to learn about urological health,...
/PRNewswire/ -- Patients are turning to social media channels more and more frequently to learn about urological health, but the quality of information is...
/PRNewswire/ -- Patients are turning to social media channels more and more frequently to learn about urological health, but the quality of information is...